GlaxoSmithKline halts production of some Excedrin products - ABC News

Pharmaceutical giant GlaxoSmithKline has temporarily stopped production of Excedrin, its popular over-the-counter migraine medication.
GlaxoSmithKline does not know when it will resume producing Excedrin.
The drug’s maker found problems in how ingredients were measured in Excedrin Extra Strength and Excedrin Migraine.

Two Kinds of Popular Excedrin Products Temporarily Discontinued in 'Precautionary Measure

Production for some Excedrin products temporarily paused

Scope of Cyber Security in Germany

In First-Ever Brand Extension, Excedrin Launches Heady Supplements 04/25/2023

GlaxoSmithKline fined $3bn after bribing doctors to increase drugs sales, GlaxoSmithKline

GlaxoSmithKline halts production of some Excedrin products - ABC News

FDA approves injectable form of GSK HIV prevention drug

Is GlaxoSmithKline Cruelty-Free or Vegan? » Vegan Rabbit

Excedrin shortage: Drugmaker GlaxoSmithKline confirms there's a nationwide shortage of some Excedrin products - ABC7 Los Angeles

Excedrin Migraine Extra Strength Walmart Shop Now

Video FDA approves nasal spray for migraines - ABC News